Once-daily indinavir plus ritonavir: preliminary results of the PIPO study

AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / pharmacokinetics*
  • Humans
  • Indinavir / adverse effects*
  • Indinavir / pharmacokinetics*
  • Male
  • Pilot Projects
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / adverse effects*
  • Ritonavir / pharmacokinetics*
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Indinavir
  • Ritonavir